(a)  Establishment; appointment

The Secretary shall establish within the Office of the Commissioner an office to be known as the Office of the Chief Scientist. The Secretary shall appoint a Chief Scientist to lead such Office.

(b)  Duties of the Office

The Office of the Chief Scientist shall⁠—

(1)  oversee, coordinate, and ensure quality and regulatory focus of the intramural research programs of the Food and Drug Administration;

(2)  track and, to the extent necessary, coordinate intramural research awards made by each center of the Administration or science-based office within the Office of the Commissioner, and ensure that there is no duplication of research efforts supported by the Reagan-Udall Foundation for the Food and Drug Administration;

(3)  develop and advocate for a budget to support intramural research;

(4)  develop a peer review process by which intramural research can be evaluated;

(5)  identify and solicit intramural research proposals from across the Food and Drug Administration through an advisory board composed of employees of the Administration that shall include⁠—

(A)  representatives of each of the centers and the science-based offices within the Office of the Commissioner; and

(B)  experts on trial design, epidemiology, demographics, pharmacovigilance, basic science, and public health; and

(6)  develop postmarket safety performance measures that are as measurable and rigorous as the ones already developed for premarket review.